Eli Lilly still confident in benefits of Covid antibody treatment despite end to hospital study

"It's disappointing, of course. We would have liked to have shown a benefit in the hospital," Eli Lilly CEO Dave Ricks told CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.